4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions
Information source: Oregon Health and Science University
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pain
Intervention: Intrauterine lidocaine infusion 4% (Drug)
Phase: N/A
Status: Completed
Sponsored by: Oregon Health and Science University Official(s) and/or principal investigator(s):
Alison B Edelman, MD, MPH, Principal Investigator, Affiliation: Oregon Health and Science University
Summary
Recent studies have investigated the use of local anesthetics (i. e. lidocaine, mepivacaine)
to lessen the pain experienced with minor gynecologic procedures such as endometrial biopsy
and office hysteroscopy. Local anesthetic injected into the uterine cavity has been
demonstrated effective in some studies at decreasing patient pain associated with these
intrauterine procedures at an anesthetic concentration of at least 2%. Based on this
evidence, we hypothesized that an intrauterine lidocaine infusion may reduce patient pain
during first trimester abortions.
Clinical Details
Official title: 4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions
Study design: Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment
Primary outcome: VAS scores during cervical dilation and uterine aspiration
Secondary outcome: Patient satisfaction, symptoms, lidocaine levels
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Age > 18 years old
- Good general health
- English speaking
- Confirmation of gestational age by ultrasound
- Body weight > 100 lbs.
- Pregnancy < 11 weeks
Locations and Contacts
Planned Parenthood of the Columbia Willamette, Portland, Oregon 97206, United States
Additional Information
Ending date: December 2004
Last updated: July 19, 2005
|
